Posts by Admin BioAlps

Secure, privacy-conscious data analytics among hospitals   The following article is part of BioAlps’ testimonial series and was written by Professeur Jean-Pierre Hubaux, Full Professor, Laboratory for Data Security at EPFL, School of Computer and Communication Sciences (IC). Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are…

Patients with sleep apnea are more at risk when infected with COVID-19   The following article is part of BioAlps’ testimonial series and was written by Mr Raja Yazigi, Co-Founder of Netsensing Technology. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and…

Bioinformatics, a crucial key to a rapid response to the COVID-19 threat   The following article is part of BioAlps’ testimonial series and was written by Dr Christine Durinx, Executive Director at the SIB Swiss Institute of Bioinformatics. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who…

In-house expertise, strategic partnerships and collaboration   The following article is part of BioAlps’ testimonial series and was written by Mrs Sandra Ruckstuhl, Head of Europe Manufacturing Sites Communications at CSL Behring. Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding and developing…

SOPHiA GENETICS and Dasa foster a new data-driven medicine era in the fight against cancer   On 23 July, SOPHiA GENETICS, leader in Data-Driven Medicine, announced the signature of a Trial Match agreement with Dasa, the largest medical diagnostic company in Latin America. The group chose the SOPHiA Platform to lead the region toward an…

New MRI method, developed in Lausanne enhances eye imagery and clears new path for further research   Research from the Lausanne University Hospital (CHUV), the University of Lausanne and the Lausanne Ophthalmic Hospital Jules-Gonin, published in the Progress in Neurobiology review, details a new MRI method which enables the capture of simultaneous details about the…

Incyte inaugurates its new European HQ in Morges   In July 2020, the global pharmaceutical company, Incyte inaugurated its new production site and European headquarters, with the support of Innovaud,  in Morges in the canton of Vaud. The site will welcome 150 employees from the company’s regional and international branches which focus on regulation, clinical…

Artiria Medical raises CHF 3 million to improve stroke treatment   EPFL spin-off, Artiria Medical, is developing micro-actuated catheters and guidewires enabling surgeons to navigate quickly but surely through cerebral arteries. The startup raised CHF 3 million series A from Swiss investors such as 4FO Venture Partners, investiere, Zürcher Kantonal Bank (ZKB), Venture Kick, NEST…

iOnctura raise an additional €5.1 million for their series A funding, reaching a total of €20.1 million   The Geneva-based startup, iOnctura, focuses on clinical stage biopharmaceutical development of different next-generation molecules targeting cancer fibrosis. The startup announced on 14 July 2020 raising another €5.1 million euros from a new investor 3B Future Health Fund,…